Download video

Managing Toxicities of CDK4/6 Inhibitors in Hormone Positive Breast Cancer - Dr. Stephanie Graff

3.1K views

OncBrothers: Practice-Changing Cancer Discussions

10 days ago

Managing Toxicities of CDK4/6 Inhibitors in Hormone Positive Breast Cancer - Dr. Stephanie Graff

Managing Toxicities of CDK4/6 Inhibitors in Hormone Positive Breast Cancer - Dr. Stephanie Graff

Managing Toxicities of CDK4\/6 Inhibitors in Hormone Positive Breast Cancer - Dr. Stephanie Graff
22:22
Managing Toxicities of CDK4\/6 Inhibitors in Hormone Positive Breast Cancer - Dr. Stephanie Graff
by OncBrothers: Practice-Changing Cancer Discussions
The OncoAlert TOP5 of Day 2 of #esmo25 :DESTINY Breast 11, DESTINY Breast 05, KN905, evERA \& RAMPART
3:36
The OncoAlert TOP5 of Day 2 of #esmo25 :DESTINY Breast 11, DESTINY Breast 05, KN905, evERA \& RAMPART
by OncoAlert 360
Optimal Management of Brain Metastases in Patients with HER2-Positive Breast Cancer
45:42
Optimal Management of Brain Metastases in Patients with HER2-Positive Breast Cancer
by Research To Practice
Managing toxicities of treatment
1:10:27
Managing toxicities of treatment
by Living Beyond Breast Cancer
Managing ADC toxicities in HER2+ metastatic breast cancer
6:40
Managing ADC toxicities in HER2+ metastatic breast cancer
by COR2ED The Heart of Medical Education
Digging Deep and Doing Better Part 2
31:32
Digging Deep and Doing Better Part 2
by NSVRC
Targeting Cancer at the Molecular Level: Repurposed Drugs and Integrative Strategies
58:39
Targeting Cancer at the Molecular Level: Repurposed Drugs and Integrative Strategies
by Fit Rx Health + Wellness
Evolving Conversations in HER2+ Oligometastatic Breast Cancer Management
21:54
Evolving Conversations in HER2+ Oligometastatic Breast Cancer Management
by Medscape
Session 2: H\&N How to Mitigate Toxicities
1:20:28
Session 2: H\&N How to Mitigate Toxicities
by Rayos Contra Cancer
Classification of Breast Cancers; adenocarcinomas, Carcinomas, In Situ, Invasive
1:44
Classification of Breast Cancers; adenocarcinomas, Carcinomas, In Situ, Invasive
by MBBS NAIJA
Toxicology
23:11
Toxicology
by Science Academy by Mukhtar
Best practices in molecular testing and targeted therapy for HR+\/HER2- metastatic breast cancer
5:52
Best practices in molecular testing and targeted therapy for HR+\/HER2- metastatic breast cancer
by COR2ED The Heart of Medical Education
Symposium | Panel discussion | Strategies for the management of treatment-related toxicities in MM
11:31
Symposium | Panel discussion | Strategies for the management of treatment-related toxicities in MM
by Multiple Myeloma Hub
Tox in Your Backyard
27:32
Tox in Your Backyard
by Society of Toxicology (SOT)
CDK4\/6 inhibitor switching in HR+\/HER2- metastatic breast cancer
0:48
CDK4\/6 inhibitor switching in HR+\/HER2- metastatic breast cancer
by VJOncology
Second-to-none: Understanding the risks of secondary poisoning
41:36
Second-to-none: Understanding the risks of secondary poisoning
by British Pest Control Association
What does it mean to be HER2 Positive in Lung Cancer
21:27
What does it mean to be HER2 Positive in Lung Cancer
by OncBrothers: Practice-Changing Cancer Discussions
Managing CDK4\/6 Inhibitor Toxicities in Breast Cancer
8:29
Managing CDK4\/6 Inhibitor Toxicities in Breast Cancer
by The Association of Cancer Care Centers
2025 International Symposium on Malignant Mesothelioma Day 2
8:28:56
2025 International Symposium on Malignant Mesothelioma Day 2
by Mesothelioma Applied Research Foundation
Episode 2 - Conversations in Relapsed\/Refractory Multiple Myeloma
18:18
Episode 2 - Conversations in Relapsed\/Refractory Multiple Myeloma
by Practice Point Communications